Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2000. Start Trial.
Date Value
October 23, 2026 6.743M
October 22, 2026 6.813M
October 21, 2026 6.533M
October 20, 2026 5.670M
October 19, 2026 5.577M
October 16, 2026 5.740M
October 15, 2026 5.926M
October 14, 2026 5.833M
October 13, 2026 5.973M
October 12, 2026 5.973M
October 09, 2026 6.020M
October 08, 2026 5.973M
October 07, 2026 6.300M
October 06, 2026 6.206M
October 05, 2026 6.766M
October 02, 2026 6.953M
October 01, 2026 7.140M
September 30, 2026 7.000M
September 29, 2026 7.210M
September 28, 2026 7.420M
September 25, 2026 7.560M
September 24, 2026 7.280M
September 23, 2026 7.840M
September 22, 2026 8.026M
September 21, 2026 7.653M
Date Value
September 18, 2026 7.326M
September 17, 2026 7.420M
September 16, 2026 7.560M
September 15, 2026 7.513M
September 14, 2026 7.816M
September 11, 2026 7.840M
September 10, 2026 7.746M
September 09, 2026 8.026M
September 08, 2026 8.166M
September 04, 2026 8.353M
September 03, 2026 8.259M
September 02, 2026 8.259M
September 01, 2026 8.446M
August 31, 2026 8.586M
August 28, 2026 8.446M
August 27, 2026 8.446M
August 26, 2026 8.586M
August 25, 2026 8.726M
August 24, 2026 8.399M
August 21, 2026 8.633M
August 20, 2026 8.353M
August 19, 2026 8.353M
August 18, 2026 8.353M
August 17, 2026 8.446M
August 14, 2026 8.679M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 534.42M
Amgen, Inc. 280.78B
Anika Therapeutics, Inc. 273.50M
BioCryst Pharmaceuticals, Inc. 2.436B
Curis, Inc. -3.820M

Enterprise Value Related Metrics